Total Funding
69
25
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1290460
Dekkun develops a humanized monoclonal antibody, DKN-01, for the treatment of cancer and for strengthening cancer-associated bone lesions.
About the Company
Dekkun Corporation is in stealth mode, it intends to develop pharmaceutical technologies. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.
